Progressive multifocal leukoencephalopathy confirmed by PCR: Case report;Leucoencefalopatia multifocal progressiva confirmada por PCR para vírus JC no líquor: Relato de caso

Arquivos de Neuro-Psiquiatria

Volumn 62, Issue 2 B, 2004, Pages 550-554

  Pasqualotto, Alessandro Comarú ^a,b,d   De Mattos, Alice J Z ^a,c   Rocha, Marineide Melo ^a,b  

^a HOSPITAL NOSSA SENHORA DA CONCEIÇÃO   (Brazil)

^b Serviço de Infectologia Rede Hospitalar Privada e Câmara Técnica Doenças Infecciosas do CREMERJ   (Brazil)

^c Serviço de Neurologia

^d NONE   (Brazil)

Author keywords

AIDS; HAART; HIV infections; JC virus; Polymerase chain reaction; Progressive multifocal leukoencephalopathy

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; NELFINAVIR; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; DIFFERENTIAL DIAGNOSIS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; NEURORADIOLOGY; PATIENT CARE; POLYMERASE CHAIN REACTION; PROGNOSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SURVIVAL; SYSTEMATIC REVIEW; TREATMENT INDICATION;

EID: 3142709645     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2004000300034     Document Type: Article

References (28)

1. Hallervorden J. Eigennartige und nicht rubriziebare Prozesse. In Bumke O (ed). Handbuch der Geiteskranheiten: Vol. 2. Die Anatomie der Psychosen. Berlin: Springer, 1930.
2. Aström KE, Mancall EL, Richardson EP Jr. Progressive multifocal leukoencephalopathy: a hitherto unrecognized complication of chronic lymphocytic leukemia and lymphoma. Brain 1958;81:93-111.
3. Padgett BL, ZuRhein G, Walker D, et al. Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet 1971;1:1257-1260.
4. Brooks BR, Walker DL. Progressive multifocal leukoencephalopathy. Neurol Clin 1984;2:299-313.
5. Miller JR, Barret RE, Britton CB, et al. Progressive multifocal leukoencephalopathy in a male homossexual with T-cell immune deficiency. N Engl J Med 1982;307:1436-1438.
6. Berger JR, Major EO. Progressive multifocal leukoencephalopathy. Sem Neurol 1999;19:193-200.
7. Fazakerley JK, Walker R. Virus demyelination. J Neurovirol 2003;9:148-164.
8. Stoner GL, Ryschkewitsch CF, Walker DL, et al. JC papovavirus large tumor (T)-antigen expression in brain tissue of acquired immune deficiency syndrome (AIDS) and non-AIDS patients with progresive multifocal leukoencephalopathy. Proc Natl Acd Sci USA 1986;23:2271-2275.
9. Seth P, Diaz F, Major EO. Advances in the biology of JC virus and induction of progressive multifocal leukoencephalopathy. J Neurovirol 2003;9:236-246.
10. Omerud LD, Rhodes RH, Gross AS, et al. Ophtalmologic manifestations of acquired immune deficiency sydrome-associated progresive mulfifocal leukoencephalopathy. Ophtalmology 1996;103:899-906.
11. Skiest DJ. Focal neurological disease in patients with acquired immunodeficiency syndrome. Clin Infect Dis 2002;34:103-115.
12. Whiteman M, Post MJD, Berger JR, et al. PML in 47 HIV + patients. Radiology 1993;187:233-240.
13. Mamidi A, DeSimone JA, Pomerantz RJ. Central nervous system infections in individuals with HIV-1 infection. J Neurovirol 2002;8:158-167.
14. Fong IW, Britton CB, Luinstra KE, et al. Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Clin Microbiol 1995;33:484-486.
15. McGuire D, Barhite S, Hollander H, et al. JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value of progressive multifocal leukoencephalopathy. Ann Neurol 1995;37:935-939.
16. Weber T, Turner RW, Frye S, et al. Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction. J Infect Dis 1994;169:1138-1141.
17. Antinori A, Ammassari A, De Luca A, et al. Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology 1997;48:687-694.
18. Baqi M, Kucharczyk W, Walmsley SL. Regression of progressive multifocal leukoencephalopathy with highly active antiretroviral therapy (letter). AIDS 1997;11:1526-1527.
19. De Luca A, Giancola ML, Ammassari A, et al. Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy. AIDS 2000;14:117-121.
20. Baldweg T, Catalan J. Remission of progressive multifocal leukoencephalopathy after antiretroviral therapy. Lancet 1997;349:1554-1155.
21. Cinque P. Progressive multifocal leukoencephalopathy, HIV, and highly active antiretroviral therapy. N Engl J Med 1998;339:848-849.
22. De Luca A. Giancola ML, Ammassari A, et al. The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy. J Infect Dis 2000;182:1077-1083.
23. Clifford DB, Yiannoutsos C, Glicksman M, et al. HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 1999;52:623-625.
24. Tassie JM, Gasnault J, Bentata M, et al. Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. Clinical Epidemiology Group. French Hospital Database on HIV. AIDS 1999;13:1881-1887.
25. Giudici B, Vaz B, Bossolasco S, et al. Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis 2000;30:95-99.
26. Tantisiriwat W, Tebas P, Clifford DB, et al. Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy. Clin Infect Dis 1999;28:1152-1154.
27. DeSimone JA, Pomerantz RJ, Babinchak T. Inflammatory reactions in HIV-1 infected person after iniciation of highly active antiretroviral therapy. Ann Intern Med 2000;133:447-454.
28. Mirailes P, Berenguer J, Lacruz C, et al. Paradoxical worsening of AIDS-associated progressive multifocal leukoencephalopathy following HAART. 8th Conference on Retroviruses and Opportunistic Infections. Abstract 598. Chicago, 2001.